Governor Deval Patrick toured and visited with workers at Nuclea Biotechnologies, a biotechnology services company that has developed a novel technology platform to improve the efficiency of diagnostics and drug discovery research.
Headquartered in Pittsfield, with additional operations in Worcester and Cambridge, Nuclea has developed and is commercializing unique diagnostic tests for colon, breast, leukemia, lung and prostate cancer. Nuclea also performs research leading to novel molecular oncology companion diagnostics for the pharmaceutical and biotechnology industries.
